Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Chunmeng Qin"'
Publikováno v:
Pharmaceutical Biology, Vol 62, Iss 1, Pp 634-647 (2024)
Context In China, HUANGQI is widely used for the treatment of Alzheimer’s disease (AD). However, a comprehensive understanding of its mechanism of anti-AD effects is lacking.Objective To explore the active ingredients of HUANGQI and its potential t
Externí odkaz:
https://doaj.org/article/9da1e2e3ad4e46718cbf58deffecd164
Publikováno v:
Therapeutic Advances in Drug Safety, Vol 15 (2024)
Background: The use of antineoplastic agents is one of the important triggers of tumor lysis syndrome (TLS), but there is still a lack of comprehensive understanding of antineoplastic agents that may trigger TLS and the TLS risk differences between d
Externí odkaz:
https://doaj.org/article/f312a8e72a344cb3a3005fc8aba70ae1
Autor:
Dongxuan Li, Shuang Chai, Hongli Wang, Jie Dong, Chunmeng Qin, Dan Du, Yalan Wang, Qian Du, Songqing Liu
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Introduction: Drug-induced QT prolongation and (or) Torsade de Pointes (TdP) is a well-known serious adverse reaction (ADR) for some drugs, but the widely recognized comprehensive landscape of culprit-drug of QT prolongation and TdP is currently lack
Externí odkaz:
https://doaj.org/article/cbf49d151a064811856d1013b79ca384
Autor:
Dongxuan Li, Jinghui Gou, Jun Zhu, Tongyan Zhang, Feng Liu, Daojun Zhang, Liyang Dai, Wenjun Li, Qinglong Liu, Chunmeng Qin, Qian Du, Songqing Liu
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Background: Sound drug safety information is important to optimize patient management, but the widely recognized comprehensive landscape of culprit-drugs that cause severe cutaneous adverse reactions (SCARs) is currently lacking.Objective: The main a
Externí odkaz:
https://doaj.org/article/4e6cff715e6e47029cad3bc2eebd9464
Autor:
Dongxuan Li, Yi Song, Zhanfeng Bai, Xin Xi, Feng Liu, Yang Zhang, Chunmeng Qin, Dan Du, Qian Du, Songqing Liu
Publikováno v:
Antibiotics, Vol 12, Iss 7, p 1109 (2023)
Antibacterial drug exposure (ADE) is a well-known potential risk factor for Clostridium difficile infection (CDI), but it remains controversial which certain antibacterial drugs are associated with the highest risk of CDI occurrence. To summarize CDI
Externí odkaz:
https://doaj.org/article/d8a56f715cf04fb2b989d43273afe8bc
Autor:
Liu, Dongxuan Li, Yi Song, Zhanfeng Bai, Xin Xi, Feng Liu, Yang Zhang, Chunmeng Qin, Dan Du, Qian Du, Songqing
Publikováno v:
Antibiotics; Volume 12; Issue 7; Pages: 1109
Antibacterial drug exposure (ADE) is a well-known potential risk factor for Clostridium difficile infection (CDI), but it remains controversial which certain antibacterial drugs are associated with the highest risk of CDI occurrence. To summarize CDI
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=multidiscipl::e071db26eb200f034cce3cfecf40d523